MENU
+Compare
LLY
Stock ticker: NYSE
AS OF
Jan 17 closing price
Price
$725.72
Change
-$31.88 (-4.21%)
Capitalization
739.66B

LLY Eli Lilly & Co Forecast, Technical & Fundamental Analysis

a manufacturer of pharmaceutical products

LLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for LLY with price predictions
Jan 08, 2025

LLY's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for LLY turned positive on December 23, 2024. Looking at past instances where LLY's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 52 cases where LLY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LLY advanced for three days, in of 353 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 08, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on LLY as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LLY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LLY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: LLY's P/B Ratio (67.114) is very high in comparison to the industry average of (5.632). P/E Ratio (131.129) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (1.440) is also within normal values, averaging (3.004). Dividend Yield (0.006) settles around the average of (0.164) among similar stocks. LLY's P/S Ratio (20.121) is very high in comparison to the industry average of (3.643).

View a ticker or compare two or three
LLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

LLY is expected to report earnings to rise 365.25% to $5.49 per share on February 06

Eli Lilly & Co LLY Stock Earnings Reports
Q4'24
Est.
$5.49
Q3'24
Missed
by $0.27
Q2'24
Beat
by $1.18
Q1'24
Beat
by $0.10
Q4'23
Beat
by $0.18
The last earnings report on October 30 showed earnings per share of $1.18, missing the estimate of $1.45. With 5.56M shares outstanding, the current market capitalization sits at 739.66B.
A.I.Advisor
published Dividends

LLY paid dividends on December 10, 2024

Eli Lilly & Co LLY Stock Dividends
А dividend of $1.30 per share was paid with a record date of December 10, 2024, and an ex-dividend date of November 15, 2024. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Lilly Corporate Center
Phone
+1 317 276-2000
Employees
43000
Web
https://www.lilly.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HWM125.302.32
+1.89%
Howmet Aerospace
ESLA1.180.01
+0.68%
Estrella Immunopharma
OSW19.590.10
+0.51%
OneSpaWorld Holdings Limited
CPRI23.820.04
+0.17%
Capri Holdings Limited
NATH78.080.02
+0.03%
Nathan's Famous

LLY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LLY has been loosely correlated with NVS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if LLY jumps, then NVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LLY
1D Price
Change %
LLY100%
-4.21%
NVS - LLY
42%
Loosely correlated
-0.34%
OGN - LLY
25%
Poorly correlated
-2.72%
AZN - LLY
22%
Poorly correlated
-0.46%
JNJ - LLY
21%
Poorly correlated
-0.50%
ABBV - LLY
21%
Poorly correlated
-1.23%
More